Head-to-head · Cost-Efficiency Index
Invigor Medical vs Shed (tryshed.com)
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Invigor Medical
Value shoppers who want competitive pricing on both molecules plus a wider wellness/hormone program on one account.
Visit Invigor MedicalShed (tryshed.com)
People who want to try alternative formats (drops, lozenges, microdose) or a brand pill under one named care team, with a money-back window to de-risk the commitment.
Visit Shed (tryshed.com)The verdict
Invigor Medical takes it, leading the Cost-Efficiency Index 88 to 85. Solid mid-market cost on both molecules from an established operator — good value if you also want a broader metabolic and hormone catalog. Shed (tryshed.com) still earns a B — People who want to try alternative formats (drops, lozenges, microdose) or a brand pill under one named care team, with a money-back window to de-risk the commitment.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Invigor Medical.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Invigor Medical | Shed (tryshed.com) |
|---|---|---|
| Cost-Efficiency Index | 88/100 | 85/100 |
| Semaglutide / mo | $199/mo | $159/mo |
| Tirzepatide / mo | $339/mo | $239/mo |
| Semaglutide / yr (modeled) | $2,388 | $1,908 |
| Tirzepatide / yr (modeled) | $4,068 | $2,868 |
| Coverage | Not disclosed | Not disclosed |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Yes |
| Rank on the board | #2 | #10 |
Invigor Medical
88/100Where the value is
- Competitive mid-market pricing on both semaglutide and tirzepatide
- Long-running operator with a broad catalog that can consolidate spend
- Both molecules published up front for easy cost modeling
The tradeoffs
- Does not publish an explicit states-served list, so access is a variable in the model
- Compounded only
Shed (tryshed.com)
85/100Where the value is
- Unusually wide formats — compounded injections plus drops, lozenges and microdosing, and a brand Wegovy pill (~$149) for the needle-averse
- Named care team (Dr. Asad Niazi plus a nurse, dietitian and coach) rather than an anonymous clinician pool
- 120-day money-back guarantee lowers the risk of committing
The tradeoffs
- The novel formats (drops, lozenges, microdose) haven't been evaluated by the FDA for this use
- No LegitScript certification, founding year or parent company published, so verification is thinner
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.